Respiratory Tract Infection Treatment Market report includes historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. Respiratory Tract Infection Treatment Market offers complete, proficient report delivering market research data that is relevant for new market entrants or set up players. Key strategies of the companies operating in the market and their impact analysis have been included in the report.
Respiratory diseases such as bronchitis, asthma, allergic rhinitis, pneumonia, and sinusitis can significantly curtail the physical activities of the individual. The symptoms associated with both mild and severe indication of these respiratory conditions include coughing, wheezing, chest pain, respiratory distress, and shortness of breath, congestion, and even death in severe cases. These conditions lead to substantial morbidity and cause large financial burden to the society.
Get Your FREE Sample Copy of the Respiratory Tract Infection Treatment Market Report 2021
Therefore, the development of new drugs (having less adverse effects) for treatment of respiratory tract infection is a major concern for manufacturers, as several generic drugs are available in the market.
The global respiratory tract infection treatment market was valued at US$ 35.64 Bn in 2017, and is expected to witness a CAGR of 6.5% over the forecast period (2018 – 2026).
Figure 1. Global Respiratory Tract Infection Treatment Market Share Analysis (%), By Product Type
Source: Coherent Market Insights Analysis (2018)
The respiratory tract infection treatment market is expected to exhibit exponential growth over the forecast period. This is owing to increasing pollution, which is resulting in rising number of cases of respiratory tract infection. According to a National Center for Biotechnology Information (NCBI), 2013, in the U.S., 25% people are suffering from upper respiratory tract infection due to pollution and it is the most common reason for patients to visit the doctors. Novel lung therapies are being developed by various research organizations for the treatment of critically ill patients with acute respiratory distress syndrome (ARDS). For instance, Draper Laboratory scientists are using unique manufacturing techniques and chip technology to precisely mimic blood vessels in the lungs, to treat patients with lung failure.
Furthermore, asthma is one among the major conditions that leads to respiratory diseases, which are characterized by recurring attacks of panting and wheezing. The severity and frequency of asthma differs from individual to individual. According to the Centers for Disease Control and Prevention (CDC), in 2015, 25 million people (1 in 13) in the U.S. were suffering from asthma. Furthermore, 6.2 million people below the age of 18 years suffered from asthma.
Buy Now this Premium Report to Grow your Business: https://www.coherentmarketinsights.com/insight/buy-now/2030
Reasons to Purchase this Report
• Current and future of global Respiratory Tract Infection Treatment market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
“Limited Time Offer”
Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.
We also offer 15% FREE Report customization.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/2030
The respiratory tract infection treatment market growth is driven by factors such as strategies adopted by vendors for implementing new schemes and reimbursement rate for respiratory diseases that would attract the patients to undergo treatment. As per the data from GlaxoSmithKline (GSK) Australia, Trelegy Ellipta (single inhaler triple therapy for COPD) will be reimbursed by the Pharmaceutical Benefits Scheme (PBS) for suitable adults in Australia suffering from moderate to severe chronic obstructive pulmonary diseases (COPD) from June 1, 2018. Moreover, the market growth is expected to be driven by rising approval of new drugs by the Food and Drug Administration (FDA). For instance, in November 2017, the U.S. FDA approved Fasenra (Benralizumab) manufactured by AstraZeneca, a respiratory biologic for the patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype. Furthermore, in November 2017, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the marketing authorization of Benralizumab. Benralizumab is also under regulatory review in Japan and several other countries.
Key Takeaways of the Respiratory Tract Infection Treatment Market:
- The global respiratory tract infection treatment market is expected to exhibit a CAGR of 6.5% during the forecast period (2018 – 2026). This is attributed to continuous technological advancements and rising incidence of respiratory diseases.
- Among drug class, non-steroidal anti-inflammatory drug (NSAIDS) segment is expected to exhibit rapid growth during the forecast period. This is due to easy availability of these drugs under over the counter (OTC) products at low price.
- However, antibiotics segment is expected to exhibit fastest growth rate in this market, as these drugs have improved pharmacokinetics that specifically target the respiratory tract infection and also due to rising prescription of antibiotics for curing respiratory tract infection
- Key players operating in the global respiratory tract infection treatment market include Abbott Laboratories, AstraZeneca, Plc, Abbvie Inc., Boehringer Ingelheim GmbH, Cipla Pharmaceutical Company, GlaxoSmithKline plc, Pfizer Inc., Merck & Co., Novartis AG, F. Hoffman La Roche Ltd, Sanofi, and Teva Pharmaceutical Industries Ltd.
Browse 25 Market Data Tables and 22 Figures spread through 157 Pages and in-depth TOC on “Respiratory Tract Infection Treatment Market, by Drug Class (Antibiotics, Non-Steroidal Anti-Inflammatory Drug (NSAIDS), Cough Suppressant, Nasal Decongestant, and Others), by Disease Indication (Upper Respiratory Tract Infection and Lower Respiratory Tract Infection), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2026”
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Disease Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Pipeline Analysis
- Epidemiology
- PEST Analysis
- PORTER’S Analysis
- Market Dynamics
- Global Respiratory Tract Infection Treatment Market, By Drug Class, 2016–2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017–2026
- Segment Trends
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- Cough Suppressant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- Nasal Decongestant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- Introduction
- Global Respiratory Tract Infection Treatment Market, By Disease Indication, 2016–2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017–2026
- Segment Trends
- Upper Respiratory Tract Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- Lower Respiratory Tract Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- Introduction
- Global Respiratory Tract Infection Treatment Market, By Distribution Channel, 2016–2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017–2026
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- Introduction
- Global Respiratory Tract Infection Treatment Market, By Region, 2016–2026, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, By Region, 2016–2026
- Regional Trends
- North America
- Market Size and Forecast, By Drug Class, 2016–2026, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2016–2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016–2026, (US$ Million)
- Market Size and Forecast, By Country, 2016–2026, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Drug Class, 2016–2026, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2016–2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016–2026, (US$ Million)
- Market Size and Forecast, By Country, 2016–2026, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Class, 2016–2026, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2016–2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016–2026, (US$ Million)
- Market Size and Forecast, By Country, 2016–2026, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Drug Class, 2016–2026, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2016–2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016–2026, (US$ Million)
- Market Size and Forecast, By Country, 2016–2026, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Drug Class, 2016–2026, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2016–2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016–2026, (US$ Million)
- Market Size and Forecast, By Country, 2016–2026, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Middle East
- Market Size and Forecast, By Drug Class, 2016–2026, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2016–2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016–2026, (US$ Million)
- Market Size and Forecast, By Country, 2016–2026, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
Major Point Answered in Respiratory Tract Infection Treatment Market Research Study are: –
• What will the market growth rate, Overview, and Analysis by Type of Respiratory Tract Infection Treatment market in 2026?
• What are the key factors driving, Analysis by Applications and Countries Respiratory Tract Infection Treatment market?
• What are Dynamics, This Overview Includes Analysis of Scope and price analysis of top Manufacturers Profiles of Respiratory Tract Infection Treatment market?
• Who are the Opportunities, Risk, and Driving Force of Respiratory Tract Infection Treatment market? Knows Upstream Raw Materials Sourcing and Downstream Buyers
• Who are the key vendors in Respiratory Tract Infection Treatment market space? Business Overview by Type, Applications, Gross Margin and Market Share
• What are the Respiratory Tract Infection Treatment market opportunities and threats faced by the vendors in the market?
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837